Congenital Muscular Dystrophy Ascending Multiple Dose Cohort Study Analyzing Pharmacokinetics at Three Dose Levels In Children and Adolescents With Assessment of Safety and Tolerability of Omigapil (CALLISTO)
Clinical trial NCT01805024 · COMPLETED
Trial details
- NCT number
- NCT01805024
- Sponsor
- Santhera Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2017-12-05
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.